🔴 Cresco Labs is trading 6.1% down today after adjusted EBITDA declined year over year

Cresco Labs is trading 6.1% down at $0.66 after releasing mixed second-quarter results before the August 6, 2026 market open.

• Revenue rose to $173.34 million, and net income reached $15.37 million.
• Adjusted EBITDA declined year over year to $39.54 million, while operating income fell to $13.36 million.
• The broader market is mixed, with technology shares under pressure; trading context and volume data are unavailable.